re: New MS Drug Ocrevus Wins FDA Approval

quote:

---

A step in the right direction? I hope so...

---

Cheaper insulin glargine is a step in the right direction but FWIW Basaglar costs a drop in the bucket less than Lantus.

My Medicare D patients with both COPD and diabetes are in the annual coverage gap by May, then their inhalers and DM injections ~ $1000 a month.

Branded meds used to be more reasonably priced. It's a long story.